Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet

Sharon M. Donovan, Jane Chen Jui Chao, Ruurd T. Zijlstra, Jack Odie

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: The purpose of the current study was to determine the degree to which milk-borne insulin-like growth factor-I (IGF-I) is absorbed. Methods: Cesarean-derived piglets were fitted with umbilical arterial and venous catheters within 2 h of birth and were administered formula containing 21.7 ± 1.8 μCi of iodinated recombinant human IGF-1 (125I-rhIGF-I) by orgogastric garage. Blood samples were taken before administration of the 125I-rhIGF-I (t0) and for 4 h postgavage. Plasma was obtained by centrifugation and total and trichloroacetic acid precipitable radioacitvity were determined. Immunoreactive 125I-rhIGF-I was assessed using a polyclonal antibody to human IGF-I. Four hours after feeding, intestines were removed, divided into 13 segments, and flushed with saline. Radioactivity within the small intestinal lumen and wall were measured. Results: Radioactivity in portal blood was higher than tO at all times points (p <0.05), whereas arterial radioactivity did not differ from to until 30 min postgavage. On average 18-20% of total radioactivity in both portal and arterial blood was acidprecipitable, with the proportion decreasing over time (p <0.001). Immunoprecipitable radioactivity averaged 3-5% of the total radioactivity and was higher in portal than arterial blood (p <0.05). Based on a plasma volume of 0.062 ± 0.005 L and a baseline plasma IGF-I concentration of 1.81 ± 0.56 nmol/L, absorbed 125I-rhIGF-I represented 0.205% of the total plasma IFG-I pool, whereas 14% of the dose was associated with the lining of the intestine. Conclusions: Absorption of orally administered IGF-I does not contribute significantly to circulating IGF-I.

Original languageEnglish
Pages (from-to)174-182
Number of pages9
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume24
Issue number2
DOIs
Publication statusPublished - 1997

Fingerprint

insulin-like growth factor I
Insulin-Like Growth Factor I
Radioactivity
piglets
neonates
blood
intestines
Intestines
umbilicus
trichloroacetic acid
Umbilicus
Trichloroacetic Acid
polyclonal antibodies
catheters
Plasma Volume
centrifugation
Centrifugation
Milk
Catheters
milk

Keywords

  • Intestine
  • Piglet Milk
  • Soy Insulin like growth factor

ASJC Scopus subject areas

  • Gastroenterology
  • Histology
  • Medicine (miscellaneous)
  • Food Science
  • Pediatrics, Perinatology, and Child Health

Cite this

Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet. / Donovan, Sharon M.; Chao, Jane Chen Jui; Zijlstra, Ruurd T.; Odie, Jack.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 24, No. 2, 1997, p. 174-182.

Research output: Contribution to journalArticle

@article{9fb8f313d24e4bff82d16babe99975d8,
title = "Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet",
abstract = "Background: The purpose of the current study was to determine the degree to which milk-borne insulin-like growth factor-I (IGF-I) is absorbed. Methods: Cesarean-derived piglets were fitted with umbilical arterial and venous catheters within 2 h of birth and were administered formula containing 21.7 ± 1.8 μCi of iodinated recombinant human IGF-1 (125I-rhIGF-I) by orgogastric garage. Blood samples were taken before administration of the 125I-rhIGF-I (t0) and for 4 h postgavage. Plasma was obtained by centrifugation and total and trichloroacetic acid precipitable radioacitvity were determined. Immunoreactive 125I-rhIGF-I was assessed using a polyclonal antibody to human IGF-I. Four hours after feeding, intestines were removed, divided into 13 segments, and flushed with saline. Radioactivity within the small intestinal lumen and wall were measured. Results: Radioactivity in portal blood was higher than tO at all times points (p <0.05), whereas arterial radioactivity did not differ from to until 30 min postgavage. On average 18-20{\%} of total radioactivity in both portal and arterial blood was acidprecipitable, with the proportion decreasing over time (p <0.001). Immunoprecipitable radioactivity averaged 3-5{\%} of the total radioactivity and was higher in portal than arterial blood (p <0.05). Based on a plasma volume of 0.062 ± 0.005 L and a baseline plasma IGF-I concentration of 1.81 ± 0.56 nmol/L, absorbed 125I-rhIGF-I represented 0.205{\%} of the total plasma IFG-I pool, whereas 14{\%} of the dose was associated with the lining of the intestine. Conclusions: Absorption of orally administered IGF-I does not contribute significantly to circulating IGF-I.",
keywords = "Intestine, Piglet Milk, Soy Insulin like growth factor",
author = "Donovan, {Sharon M.} and Chao, {Jane Chen Jui} and Zijlstra, {Ruurd T.} and Jack Odie",
year = "1997",
doi = "10.1097/00005176-199702000-00011",
language = "English",
volume = "24",
pages = "174--182",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet

AU - Donovan, Sharon M.

AU - Chao, Jane Chen Jui

AU - Zijlstra, Ruurd T.

AU - Odie, Jack

PY - 1997

Y1 - 1997

N2 - Background: The purpose of the current study was to determine the degree to which milk-borne insulin-like growth factor-I (IGF-I) is absorbed. Methods: Cesarean-derived piglets were fitted with umbilical arterial and venous catheters within 2 h of birth and were administered formula containing 21.7 ± 1.8 μCi of iodinated recombinant human IGF-1 (125I-rhIGF-I) by orgogastric garage. Blood samples were taken before administration of the 125I-rhIGF-I (t0) and for 4 h postgavage. Plasma was obtained by centrifugation and total and trichloroacetic acid precipitable radioacitvity were determined. Immunoreactive 125I-rhIGF-I was assessed using a polyclonal antibody to human IGF-I. Four hours after feeding, intestines were removed, divided into 13 segments, and flushed with saline. Radioactivity within the small intestinal lumen and wall were measured. Results: Radioactivity in portal blood was higher than tO at all times points (p <0.05), whereas arterial radioactivity did not differ from to until 30 min postgavage. On average 18-20% of total radioactivity in both portal and arterial blood was acidprecipitable, with the proportion decreasing over time (p <0.001). Immunoprecipitable radioactivity averaged 3-5% of the total radioactivity and was higher in portal than arterial blood (p <0.05). Based on a plasma volume of 0.062 ± 0.005 L and a baseline plasma IGF-I concentration of 1.81 ± 0.56 nmol/L, absorbed 125I-rhIGF-I represented 0.205% of the total plasma IFG-I pool, whereas 14% of the dose was associated with the lining of the intestine. Conclusions: Absorption of orally administered IGF-I does not contribute significantly to circulating IGF-I.

AB - Background: The purpose of the current study was to determine the degree to which milk-borne insulin-like growth factor-I (IGF-I) is absorbed. Methods: Cesarean-derived piglets were fitted with umbilical arterial and venous catheters within 2 h of birth and were administered formula containing 21.7 ± 1.8 μCi of iodinated recombinant human IGF-1 (125I-rhIGF-I) by orgogastric garage. Blood samples were taken before administration of the 125I-rhIGF-I (t0) and for 4 h postgavage. Plasma was obtained by centrifugation and total and trichloroacetic acid precipitable radioacitvity were determined. Immunoreactive 125I-rhIGF-I was assessed using a polyclonal antibody to human IGF-I. Four hours after feeding, intestines were removed, divided into 13 segments, and flushed with saline. Radioactivity within the small intestinal lumen and wall were measured. Results: Radioactivity in portal blood was higher than tO at all times points (p <0.05), whereas arterial radioactivity did not differ from to until 30 min postgavage. On average 18-20% of total radioactivity in both portal and arterial blood was acidprecipitable, with the proportion decreasing over time (p <0.001). Immunoprecipitable radioactivity averaged 3-5% of the total radioactivity and was higher in portal than arterial blood (p <0.05). Based on a plasma volume of 0.062 ± 0.005 L and a baseline plasma IGF-I concentration of 1.81 ± 0.56 nmol/L, absorbed 125I-rhIGF-I represented 0.205% of the total plasma IFG-I pool, whereas 14% of the dose was associated with the lining of the intestine. Conclusions: Absorption of orally administered IGF-I does not contribute significantly to circulating IGF-I.

KW - Intestine

KW - Piglet Milk

KW - Soy Insulin like growth factor

UR - http://www.scopus.com/inward/record.url?scp=0030934381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030934381&partnerID=8YFLogxK

U2 - 10.1097/00005176-199702000-00011

DO - 10.1097/00005176-199702000-00011

M3 - Article

C2 - 9106104

AN - SCOPUS:0030934381

VL - 24

SP - 174

EP - 182

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 2

ER -